30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA
Identifieur interne : 002828 ( Pmc/Corpus ); précédent : 002827; suivant : 00282930-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA
Auteurs : Jane M. Armer ; Bob R. Stewart ; Robin P. ShookSource :
- Journal of lymphoedema [ 1750-7235 ] ; 2009.
Abstract
Quantification of lymphoedema (LE) has been problematic, and the reported incidence of LE varies greatly among women treated with surgery and radiation for breast cancer.
This study aims to describe LE occurrence over time among breast cancer survivors using four diagnostic criteria based on three measurement techniques.
Limb volume and symptom assessment data were followed after surgery every three months for 12 months, then every six months for 30 months. Limb volume changes (LVC) were measured by circumferences and by perometry, and by symptom experience via interview. Standard survival analysis methods identified when the criteria indicating LE were met.
Trends in LE occurrence are reported for data from 211 participants. At 30 months post-treatment, LE incidence ranged from 41–91%, with 2cm being the highest estimation method and self-reported signs and symtoms (SS) the lowest.
This 30-month analysis supports the previous 12-month analysis in finding the 2cm criteria as the most liberal definition of LE. Self-reporting of heaviness and swelling, along with 10% LVC, represented the most conservative definitions (41% and 45%, respectively).
Url:
PubMed: 20182653
PubMed Central: 2826842
Links to Exploration step
PMC:2826842Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA</title><author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name></author><author><name sortKey="Stewart, Bob R" sort="Stewart, Bob R" uniqKey="Stewart B" first="Bob R" last="Stewart">Bob R. Stewart</name></author><author><name sortKey="Shook, Robin P" sort="Shook, Robin P" uniqKey="Shook R" first="Robin P" last="Shook">Robin P. Shook</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">20182653</idno><idno type="pmc">2826842</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826842</idno><idno type="RBID">PMC:2826842</idno><date when="2009">2009</date><idno type="wicri:Area/Pmc/Corpus">002828</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002828</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA</title><author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M" last="Armer">Jane M. Armer</name></author><author><name sortKey="Stewart, Bob R" sort="Stewart, Bob R" uniqKey="Stewart B" first="Bob R" last="Stewart">Bob R. Stewart</name></author><author><name sortKey="Shook, Robin P" sort="Shook, Robin P" uniqKey="Shook R" first="Robin P" last="Shook">Robin P. Shook</name></author></analytic><series><title level="j">Journal of lymphoedema</title><idno type="ISSN">1750-7235</idno><imprint><date when="2009">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title><p id="P1">Quantification of lymphoedema (LE) has been problematic, and the reported incidence of LE varies greatly among women treated with surgery and radiation for breast cancer.</p></sec><sec id="S2"><title>Aims</title><p id="P2">This study aims to describe LE occurrence over time among breast cancer survivors using four diagnostic criteria based on three measurement techniques.</p></sec><sec sec-type="methods" id="S3"><title>Methods</title><p id="P3">Limb volume and symptom assessment data were followed after surgery every three months for 12 months, then every six months for 30 months. Limb volume changes (LVC) were measured by circumferences and by perometry, and by symptom experience via interview. Standard survival analysis methods identified when the criteria indicating LE were met.</p></sec><sec id="S4"><title>Results</title><p id="P4">Trends in LE occurrence are reported for data from 211 participants. At 30 months post-treatment, LE incidence ranged from 41–91%, with 2cm being the highest estimation method and self-reported signs and symtoms (SS) the lowest.</p></sec><sec id="S5"><title>Conclusions</title><p id="P5">This 30-month analysis supports the previous 12-month analysis in finding the 2cm criteria as the most liberal definition of LE. Self-reporting of heaviness and swelling, along with 10% LVC, represented the most conservative definitions (41% and 45%, respectively).</p></sec></div></front></TEI><pmc article-type="research-article" xml:lang="EN"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">101466528</journal-id><journal-id journal-id-type="pubmed-jr-id">36617</journal-id><journal-id journal-id-type="nlm-ta">J Lymphoedema</journal-id><journal-title>Journal of lymphoedema</journal-title><issn pub-type="ppub">1750-7235</issn></journal-meta><article-meta><article-id pub-id-type="pmid">20182653</article-id><article-id pub-id-type="pmc">2826842</article-id><article-id pub-id-type="manuscript">NIHMS132326</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Armer</surname><given-names>Jane M</given-names></name></contrib><contrib contrib-type="author"><name><surname>Stewart</surname><given-names>Bob R</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shook</surname><given-names>Robin P</given-names></name></contrib><aff id="A1">Jane M Armer, Professor, Sinclair School of Nursing (SSON), Director, Nursing Research, Ellis Fischel Cancer Center; Bob R Stewart, Professor Emeritus, College of Education, Adjunct Clinical Professor, SSON; Robin P Shook, Project Development Specialist, Lymphedema Research Project, SSON, University of Missouri, Columbia, USA</aff></contrib-group><pub-date pub-type="nihms-submitted"><day>18</day><month>10</month><year>2009</year></pub-date><pub-date pub-type="ppub"><day>1</day><month>4</month><year>2009</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>2</month><year>2010</year></pub-date><volume>4</volume><issue>1</issue><fpage>14</fpage><lpage>18</lpage><abstract><sec id="S1"><title>Background</title><p id="P1">Quantification of lymphoedema (LE) has been problematic, and the reported incidence of LE varies greatly among women treated with surgery and radiation for breast cancer.</p></sec><sec id="S2"><title>Aims</title><p id="P2">This study aims to describe LE occurrence over time among breast cancer survivors using four diagnostic criteria based on three measurement techniques.</p></sec><sec sec-type="methods" id="S3"><title>Methods</title><p id="P3">Limb volume and symptom assessment data were followed after surgery every three months for 12 months, then every six months for 30 months. Limb volume changes (LVC) were measured by circumferences and by perometry, and by symptom experience via interview. Standard survival analysis methods identified when the criteria indicating LE were met.</p></sec><sec id="S4"><title>Results</title><p id="P4">Trends in LE occurrence are reported for data from 211 participants. At 30 months post-treatment, LE incidence ranged from 41–91%, with 2cm being the highest estimation method and self-reported signs and symtoms (SS) the lowest.</p></sec><sec id="S5"><title>Conclusions</title><p id="P5">This 30-month analysis supports the previous 12-month analysis in finding the 2cm criteria as the most liberal definition of LE. Self-reporting of heaviness and swelling, along with 10% LVC, represented the most conservative definitions (41% and 45%, respectively).</p></sec></abstract><kwd-group><kwd>Breast cancer</kwd><kwd>Secondary lymphoedema</kwd><kwd>Diagnostic criteria</kwd><kwd>Lymphoedema occurrence</kwd><kwd>Survival analysis</kwd></kwd-group><contract-num rid="NR1">R01 NR005342-01A1
||NR</contract-num><contract-sponsor id="NR1">National Institute of Nursing Research : NINR</contract-sponsor></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002828 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002828 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:2826842
|texte= 30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:20182653" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |